News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
879,674 Results
Type
Article (88515)
Company Profile (737)
Press Release (790392)
Multimedia
Podcasts (231)
Webinars (35)
Section
Business (233481)
Career Advice (4158)
Deals (39961)
Drug Delivery (173)
Drug Development (91586)
Employer Resources (207)
FDA (18510)
Job Trends (17476)
News (398431)
Policy (39983)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3043)
Academic (1)
Accelerated approval (51)
Adcomms (38)
Allergies (181)
Alliances (56975)
ALS (226)
Alzheimer's disease (1940)
Antibody-drug conjugate (ADC) (510)
Approvals (18820)
Artificial intelligence (777)
Autoimmune disease (322)
Automation (60)
Bankruptcy (407)
Best Places to Work (12618)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (449)
Bladder cancer (203)
Brain cancer (81)
Breast cancer (795)
Cancer (6197)
Cardiovascular disease (523)
Career advice (3592)
Career pathing (50)
CAR-T (364)
CDC (70)
Celiac Disease (3)
Cell therapy (1005)
Cervical cancer (49)
Clinical research (78483)
Collaboration (2264)
Company closure (7)
Compensation (1444)
Complete response letters (101)
COVID-19 (3027)
CRISPR (120)
C-suite (1213)
Cystic fibrosis (162)
Data (8229)
Decentralized trials (3)
Denatured (88)
Depression (183)
Dermatology (90)
Diabetes (610)
Diagnostics (7506)
Digital health (57)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (370)
Drug pricing (230)
Drug shortages (37)
Duchenne muscular dystrophy (305)
Earnings (102256)
Editorial (76)
Employer branding (25)
Employer resources (174)
Events (137595)
Executive appointments (1150)
FDA (22383)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1848)
Gene editing (263)
Generative AI (71)
Gene therapy (823)
GLP-1 (1213)
Government (5518)
Grass and pollen (7)
Guidances (411)
Healthcare (21078)
HIV (85)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (342)
Immuno-oncology (105)
Indications (197)
Infectious disease (3392)
Inflammatory bowel disease (238)
Inflation Reduction Act (17)
Influenza (143)
Intellectual property (301)
Interviews (820)
IPO (17983)
IRA (58)
Job creations (5206)
Job search strategy (2871)
JPM (72)
Kidney cancer (21)
Labor market (115)
Layoffs (678)
Leadership (51)
Legal (10157)
Liver cancer (108)
Longevity (34)
Lung cancer (817)
Lymphoma (441)
Machine learning (63)
Management (66)
Manufacturing (1142)
MASH (211)
Medical device (15189)
Medtech (15322)
Mergers & acquisitions (23214)
Metabolic disorders (1654)
mRNA (256)
Multiple sclerosis (197)
NASH (24)
Neurodegenerative disease (474)
Neuropsychiatric disorders (120)
Neuroscience (3588)
Neurotech (1)
NextGen: Class of 2026 (7693)
Non-profit (5130)
Now hiring (79)
Obesity (793)
Opinion (367)
Ovarian cancer (235)
Pain (274)
Pancreatic cancer (323)
Parkinson's disease (389)
Partnered (37)
Patents (623)
Patient recruitment (708)
Peanut (67)
People (67730)
Pharmaceutical (126)
Pharmacy benefit managers (35)
Phase 1 (24252)
Phase 2 (34116)
Phase 3 (25641)
Pipeline (9110)
Policy (383)
Postmarket research (3558)
Preclinical (10930)
Press Release (72)
Prostate cancer (320)
Psychedelics (67)
Radiopharmaceuticals (353)
Rare diseases (1201)
Real estate (7460)
Recruiting (81)
Regulatory (30101)
Reports (77)
Research institute (2753)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (28)
RSV (91)
Schizophrenia (192)
Series A (315)
Series B (228)
Service/supplier (26)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (187)
Sponsored (55)
Startups (4367)
State (2)
Stomach cancer (20)
Supply chain (134)
Tariffs (99)
The Weekly (140)
Vaccines (1251)
Venture capital (126)
Weight loss (536)
Women's health (134)
Worklife (24)
Date
Today (165)
Last 7 days (762)
Last 30 days (3669)
Last 365 days (31964)
2026 (13797)
2025 (31964)
2024 (37612)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1295)
Alabama (102)
Alaska (7)
Arizona (386)
Arkansas (16)
Asia (52091)
Australia (9165)
California (13866)
Canada (3875)
China (1464)
Colorado (595)
Connecticut (604)
Delaware (422)
Europe (119974)
Florida (2058)
Georgia (449)
Hawaii (4)
Idaho (69)
Illinois (1137)
India (97)
Indiana (623)
Iowa (25)
Japan (554)
Kansas (140)
Kentucky (54)
Louisiana (47)
Maine (82)
Maryland (1682)
Massachusetts (10070)
Michigan (385)
Minnesota (763)
Mississippi (7)
Missouri (150)
Montana (36)
Nebraska (30)
Nevada (149)
New Hampshire (90)
New Jersey (3656)
New Mexico (33)
New York (3630)
North Carolina (1869)
North Dakota (11)
Northern California (6886)
Ohio (417)
Oklahoma (26)
Oregon (53)
Pennsylvania (2751)
Puerto Rico (30)
Rhode Island (52)
South America (1667)
South Carolina (86)
South Dakota (2)
Southern California (5432)
Tennessee (217)
Texas (2220)
United States (49303)
Utah (415)
Vermont (1)
Virginia (339)
Washington D.C. (86)
Washington State (1128)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
879,674 Results for "bio path holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold
May 14, 2026
·
5 min read
Press Releases
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
April 30, 2026
·
9 min read
Huntington’s disease
UniQure’s Path for Huntington’s Gene Therapy Clouded by Ethical Questions as Potential Phase 3 Looms
While the FDA appears to be adamant that uniQure conduct a sham surgery–controlled Phase 3 trial before AMT-130 can be considered for approval, experts believe there is an alternate path forward for the therapy, perhaps even based on precedent from the recent drama surrounding Moderna’s mRNA flu vaccine.
March 5, 2026
·
7 min read
·
Heather McKenzie
Insights
What makes life science angel investment work?
In this episode of Denatured, you’ll be hearing from Yaniv Sneor, founder of the Mid Atlantic Bio Angels and Alex Pederson, an investor at Mid Atlantic Bio Angels and partner at Alloy Bio Consulting. We discuss why a life sciences-only angel group matters, how they evaluate opportunities, and the importance of strong teams, capital efficiency and a realistic path to exit.
April 30, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Immunology and inflammation
Ocular’s Hydrogel Beats Regeneron’s Eylea in Wet AMD Study, Plots Path to FDA
Following the successful late-stage study in wet age-related macular degeneration, Ocular plans to meet with the FDA to determine a regulatory path for Axpaxli.
February 17, 2026
·
2 min read
·
Tristan Manalac
Policy
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
Dallas, Texas--(Newsfile Corp. - June 4, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q1 2024.
June 4, 2024
·
1 min read
Deals
Lilly and Engage Bio tie the knot with $202M acquisition
Eli Lilly joins hands with Engage Bio, acquiring the DNA delivery platform developer in hopes of bolstering its genetic medicines portfolio.
May 20, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Bio-Path Holdings Provides Clinical and Operational Update
June 4, 2025
·
8 min read
Press Releases
Arbor Biotechnologies Achieves Unprecedented Precise In Vivo Reverse Transcriptase Editing in the Brain Using a Single AAV Vector, Opening a New Path to Treatments for Neurological Diseases
May 12, 2026
·
3 min read
Insights
Biotech angels lean into deeper diligence and disciplined early bets
Angel investors are raising the bar with tighter criteria, backing strong teams, realistic markets and clear paths to exit while applying deeper, domain-specific diligence to early stage bets.
April 29, 2026
·
4 min read
·
Jennifer C. Smith-Parker
1 of 87,968
Next